Study identifier:D9830C00021
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
An open, single centre, phase I study in male adolescents with asthma, aged 12 to 17 years, to assess pharmacokinetics of orally administered AZD1981 tablets 100 mg twice daily for 61/2 days
asthma
Phase 1
No
AZD1981 100 mg twice daily for 61/2 days
Male
21
Interventional
12 Years - 17 Years
Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 AZD1981 100 mg twice daily for 6 ½ days | Drug: AZD1981 100 mg twice daily for 61/2 days 100 mg tablets |